data_1eoq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1eoq _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.861 0.362 . . . . 5.71 110.957 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -96.46 27.05 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 3.4100000000000001 111.211 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.44 HG21 ' CE1' ' A' ' 167' ' ' PHE . 60.0 mt -93.7 94.51 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.426 0.632 . . . . 1.7 110.617 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 mtm -139.76 130.28 25.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.816 -1.084 . . . . 3.1099999999999999 110.854 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.46 141.81 55.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.823 -0.626 . . . . 2.3900000000000001 111.044 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.37 170.26 53.64 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.713 -0.676 . . . . 1.8100000000000001 113.181 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.69 -47.66 10.72 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.55 2.166 . . . . 1.96 111.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.38 36.29 4.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.91 -0.586 . . . . 3.02 111.06 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -88.41 137.99 31.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.104 -0.498 . . . . 2.6099999999999999 110.109 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 166' ' ' ASP . 0.4 OUTLIER -71.28 160.21 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.15 0.5 . . . . 2.4100000000000001 111.788 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.558 ' HE2' HG13 ' A' ' 219' ' ' ILE . 3.8 t80 -57.47 -52.0 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 2.3999999999999999 111.493 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.4 -21.37 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.213 -0.449 . . . . 2.1499999999999999 111.744 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 163' ' ' SER . 3.9 m-20 -72.56 -52.29 16.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 2.04 110.395 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.44 ' CE1' HG21 ' A' ' 156' ' ' ILE . 50.3 t80 -63.22 -55.56 23.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.32 -0.4 . . . . 2.54 111.595 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.728 ' O ' HG12 ' A' ' 172' ' ' ILE . . . -50.39 -26.21 4.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.015 0.746 . . . . 1.26 113.015 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -37.16 55.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.152 -0.684 . . . . 2.2999999999999998 109.152 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 mtt-85 -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.587 -1.264 . . . . 3.3500000000000001 107.587 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 189' ' ' ILE . 25.0 tp -67.7 -66.86 0.51 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.514 -0.766 . . . . 1.26 110.615 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 168' ' ' ALA . 44.0 mm -46.71 -52.86 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.717 -0.674 . . . . 1.5900000000000001 112.032 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -61.35 -40.17 93.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.772 -0.649 . . . . 3.48 109.53 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.31 -38.72 91.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 1.3799999999999999 110.67 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.74 -42.35 77.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 1.54 111.655 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.44 -35.85 78.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.775 0.797 . . . . 2.71 110.127 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -69.91 -16.19 72.3 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.343 -1.299 . . . . 1.48 112.561 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.38 176.84 7.02 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.073 0.464 . . . . 1.95 111.291 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.84 18.93 4.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.622 . . . . 2.29 112.303 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . 48.4 mt -70.02 133.82 87.82 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 112.081 0.4 . . . . 1.99 112.081 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 184' ' ' ALA . 16.4 Cg_exo -66.76 156.87 63.91 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.847 2.365 . . . . 1.3500000000000001 111.964 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.435 ' HA ' ' HG3' ' A' ' 185' ' ' ARG . 87.7 Cg_exo -52.82 -49.17 18.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.974 2.449 . . . . 1.45 112.62 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.7 m -66.76 -23.02 66.03 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.735 0.643 . . . . 1.96 112.735 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 181' ' ' PRO . . . -100.6 -4.9 27.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.962 0.727 . . . . 1.4099999999999999 112.962 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' HA ' ' A' ' 182' ' ' PRO . 6.9 mtm180 -62.88 -48.24 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 3.3500000000000001 110.83 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.476 ' O ' HG12 ' A' ' 190' ' ' ILE . . . -57.14 -63.6 3.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.293 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 186' ' ' ALA . 81.6 Cg_exo -43.27 -29.22 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.62 112.859 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.4 t -71.1 -53.15 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.967 -0.753 . . . . 1.27 108.967 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.508 ' CG2' ' CE2' ' A' ' 193' ' ' PHE . 1.8 mp -61.3 -36.23 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.313 -0.403 . . . . 1.48 110.932 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 186' ' ' ALA . 42.9 mm -55.53 -62.24 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 1.3100000000000001 110.188 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.222 0.453 . . . . 1.6100000000000001 112.222 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.405 ' O ' ' N ' ' A' ' 196' ' ' LYS . 0.1 OUTLIER -60.13 -46.37 89.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.27 -0.423 . . . . 1.28 110.251 -178.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 197' ' ' SER . 15.0 m-85 -57.89 -57.43 12.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.01 -0.541 . . . . 2.3399999999999999 110.824 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.492 ' HG3' ' CG2' ' A' ' 205' ' ' ILE . 9.4 mtp180 -54.58 -13.6 1.03 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.777 0.658 . . . . 2.8799999999999999 112.777 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 191' ' ' ASP . 16.7 pt20 -123.54 -8.83 7.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.326 0.862 . . . . 1.6899999999999999 113.326 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 195' ' ' GLN . 27.7 mmtt -123.13 -13.38 7.76 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.305 0.483 . . . . 3.2000000000000002 112.305 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 193' ' ' PHE . 0.4 OUTLIER -79.15 158.71 27.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 2.0 111.208 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 166.65 4.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 2.5699999999999998 111.142 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.16 -27.18 72.86 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.589 2.192 . . . . 1.5 111.774 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.29 -41.49 76.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 2.54 111.208 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.5 mm -87.21 -46.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.308 -0.406 . . . . 1.4299999999999999 111.099 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 206' ' ' ARG . 6.2 tt0 -54.13 -34.36 60.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.998 -0.546 . . . . 1.77 111.754 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -38.79 88.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 2.2200000000000002 110.646 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 208' ' ' ALA . 10.7 mt -70.04 -47.6 61.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.08 -0.964 . . . . 2.48 110.333 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.492 ' CG2' ' HG3' ' A' ' 194' ' ' ARG . 66.6 mt -68.03 -37.74 78.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.839 . . . . 1.51 111.032 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 202' ' ' GLN . 0.4 OUTLIER -54.46 -55.2 31.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.294 -0.866 . . . . 3.52 112.365 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.09 13.15 24.72 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.559 -0.456 . . . . 2.3300000000000001 111.171 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 204' ' ' LEU . . . -60.9 128.08 88.48 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 1.5600000000000001 111.575 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -71.27 -160.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.804 2.336 . . . . 2.73 111.587 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.99 159.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 2.3799999999999999 111.056 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.67 80.71 2.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.574 -0.739 . . . . 3.0800000000000001 110.119 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.7 mp -93.76 80.1 4.22 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.394 -0.965 . . . . 1.96 108.394 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 p -119.51 15.82 12.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.472 -0.785 . . . . 2.27 112.162 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.403 ' O ' HG13 ' A' ' 218' ' ' ILE . 1.5 p -147.33 167.37 13.69 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.5800000000000001 110.8 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.493 ' O ' HD12 ' A' ' 219' ' ' ILE . 10.2 Cg_exo -74.1 -42.2 0.79 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.987 2.458 . . . . 0.89000000000000001 109.942 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -53.97 -20.31 13.59 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.119 -1.401 . . . . 0.81999999999999995 112.496 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.63 -39.23 9.2 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.907 0.384 . . . . 2.3799999999999999 111.368 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.493 ' O ' HG22 ' A' ' 222' ' ' VAL . 9.9 mt -63.06 -50.77 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 1.6799999999999999 110.671 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.558 HG13 ' HE2' ' A' ' 164' ' ' PHE . 3.6 mp -62.32 -40.26 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 CA-C-O 121.071 0.463 . . . . 1.3300000000000001 110.187 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -37.85 88.88 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.354 -0.839 . . . . 3.4700000000000002 108.759 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.468 ' CE2' ' HB1' ' A' ' 208' ' ' ALA . 33.2 t80 -72.86 -37.5 67.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.482 -0.781 . . . . 2.5 111.176 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 218' ' ' ILE . 23.9 t -64.82 -45.48 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.889 -0.596 . . . . 1.3799999999999999 110.246 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.93 -31.42 59.11 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 109.098 -0.705 . . . . 1.8700000000000001 109.098 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.73 -32.52 73.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.587 -0.733 . . . . 2.0600000000000001 109.707 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.24 -28.03 22.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 3.5499999999999998 109.574 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 222' ' ' VAL . 1.2 mt-30 -79.51 8.31 6.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.733 -0.667 . . . . 2.2599999999999998 110.781 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -72.28 73.01 0.95 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.657 0.741 . . . . 4.2300000000000004 110.465 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.4 t -90.36 27.82 1.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.525 -1.216 . . . . 4.6500000000000004 111.363 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.93 110.34 9.72 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.664 0.268 . . . . 4.7999999999999998 110.471 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.832 2.354 . . . . 7.6900000000000004 112.375 -179.313 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.861 0.362 . . . . 5.4 110.957 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -96.46 27.05 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 3.41 111.211 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.532 HG22 ' CZ ' ' A' ' 167' ' ' PHE . 60.0 mt -93.7 94.51 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.426 0.632 . . . . 1.21 110.617 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 mtm -139.76 130.28 25.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.816 -1.084 . . . . 2.59 110.854 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.46 141.81 55.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.823 -0.626 . . . . 2.39 111.044 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.37 170.26 53.64 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.713 -0.676 . . . . 1.81 113.181 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.69 -47.66 10.72 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.55 2.166 . . . . 1.93 111.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.38 36.29 4.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.91 -0.586 . . . . 2.65 111.06 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -88.41 137.99 31.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.104 -0.498 . . . . 2.61 110.109 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 166' ' ' ASP . 0.4 OUTLIER -71.28 160.21 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.15 0.5 . . . . 2.04 111.788 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.873 ' CE2' HG21 ' A' ' 222' ' ' VAL . 3.8 t80 -57.47 -52.0 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 1.55 111.493 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.4 -21.37 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.213 -0.449 . . . . 1.53 111.744 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 163' ' ' SER . 3.9 m-20 -72.56 -52.29 16.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 2.04 110.395 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.532 ' CZ ' HG22 ' A' ' 156' ' ' ILE . 50.3 t80 -63.22 -55.56 23.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.32 -0.4 . . . . 1.7 111.595 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.757 ' O ' HG12 ' A' ' 172' ' ' ILE . . . -50.39 -26.21 4.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.015 0.746 . . . . 0.67 113.015 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -37.16 55.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.152 -0.684 . . . . 1.73 109.152 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 mtt-85 -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.587 -1.264 . . . . 2.65 107.587 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.759 HD23 HG23 ' A' ' 189' ' ' ILE . 25.0 tp -67.7 -66.86 0.51 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.514 -0.766 . . . . 0.53 110.615 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 168' ' ' ALA . 44.0 mm -46.71 -52.86 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.717 -0.674 . . . . 1.02 112.032 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -61.35 -40.17 93.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.772 -0.649 . . . . 2.88 109.53 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.31 -38.72 91.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 0.82 110.67 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 171' ' ' LEU . 92.6 t -70.74 -42.35 77.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.99 111.655 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.44 -35.85 78.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.775 0.797 . . . . 2.71 110.127 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -69.91 -16.19 72.3 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.343 -1.299 . . . . 1.48 112.561 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.38 176.84 7.02 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.073 0.464 . . . . 1.63 111.291 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.84 18.93 4.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.622 . . . . 2.29 112.303 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.77 HD13 HG21 ' A' ' 188' ' ' VAL . 48.4 mt -70.02 133.82 87.82 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 112.081 0.4 . . . . 1.53 112.081 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 16.4 Cg_exo -66.76 156.87 63.91 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.847 2.365 . . . . 1.04 111.964 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.533 ' HA ' ' HG3' ' A' ' 185' ' ' ARG . 87.7 Cg_exo -52.82 -49.17 18.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.974 2.449 . . . . 1.32 112.62 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.7 m -66.76 -23.02 66.03 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.735 0.643 . . . . 1.46 112.735 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -100.6 -4.9 27.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.962 0.727 . . . . 0.9 112.962 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.533 ' HG3' ' HA ' ' A' ' 182' ' ' PRO . 6.9 mtm180 -62.88 -48.24 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 2.82 110.83 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.889 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -57.14 -63.6 3.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.56 111.293 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 81.6 Cg_exo -43.27 -29.22 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.58 112.859 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.77 HG21 HD13 ' A' ' 180' ' ' LEU . 98.4 t -71.1 -53.15 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.967 -0.753 . . . . 0.63 108.967 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.759 HG23 HD23 ' A' ' 171' ' ' LEU . 1.8 mp -61.3 -36.23 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.89 110.932 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 186' ' ' ALA . 42.9 mm -55.53 -62.24 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.67 110.188 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.222 0.453 . . . . 1.61 112.222 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -60.13 -46.37 89.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.27 -0.423 . . . . 0.81 110.251 -178.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 197' ' ' SER . 15.0 m-85 -57.89 -57.43 12.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.01 -0.541 . . . . 1.45 110.824 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.507 ' HG3' ' CG2' ' A' ' 205' ' ' ILE . 9.4 mtp180 -54.58 -13.6 1.03 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.777 0.658 . . . . 2.44 112.777 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 191' ' ' ASP . 16.7 pt20 -123.54 -8.83 7.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.326 0.862 . . . . 1.69 113.326 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.465 ' HG2' ' HG3' ' A' ' 195' ' ' GLN . 27.7 mmtt -123.13 -13.38 7.76 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.305 0.483 . . . . 2.68 112.305 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 193' ' ' PHE . 0.4 OUTLIER -79.15 158.71 27.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 1.57 111.208 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 166.65 4.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 2.57 111.142 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.16 -27.18 72.86 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.589 2.192 . . . . 1.5 111.774 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.29 -41.49 76.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 2.54 111.208 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.5 mm -87.21 -46.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.308 -0.406 . . . . 0.9 111.099 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -54.13 -34.36 60.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.998 -0.546 . . . . 1.56 111.754 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -38.79 88.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 2.22 110.646 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 208' ' ' ALA . 10.7 mt -70.04 -47.6 61.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.08 -0.964 . . . . 1.85 110.333 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.507 ' CG2' ' HG3' ' A' ' 194' ' ' ARG . 66.6 mt -68.03 -37.74 78.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.839 . . . . 0.94 111.032 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.46 -55.2 31.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.294 -0.866 . . . . 3.12 112.365 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.09 13.15 24.72 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.559 -0.456 . . . . 1.96 111.171 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 1.061 ' HB2' ' O ' ' A' ' 204' ' ' LEU . . . -60.9 128.08 88.48 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 1.4 111.575 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 208' ' ' ALA . 9.4 Cg_exo -71.27 -160.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.804 2.336 . . . . 2.29 111.587 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.99 159.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 2.27 111.056 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.67 80.71 2.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.574 -0.739 . . . . 2.65 110.119 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 221' ' ' TYR . 1.7 mp -93.76 80.1 4.22 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.394 -0.965 . . . . 1.51 108.394 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 p -119.51 15.82 12.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.472 -0.785 . . . . 1.84 112.162 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.407 ' O ' HG13 ' A' ' 218' ' ' ILE . 1.5 p -147.33 167.37 13.69 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.06 110.8 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.1 -42.2 0.79 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.987 2.458 . . . . 0.76 109.942 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -53.97 -20.31 13.59 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.119 -1.401 . . . . 0.82 112.496 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.63 -39.23 9.2 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.907 0.384 . . . . 2.38 111.368 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.936 ' O ' HG23 ' A' ' 222' ' ' VAL . 9.9 mt -63.06 -50.77 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 1.05 110.671 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.572 HG13 ' HE2' ' A' ' 164' ' ' PHE . 3.6 mp -62.32 -40.26 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 CA-C-O 121.071 0.463 . . . . 0.81 110.187 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -37.85 88.88 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.354 -0.839 . . . . 3.05 108.759 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.528 ' CD2' HD21 ' A' ' 212' ' ' LEU . 33.2 t80 -72.86 -37.5 67.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.482 -0.781 . . . . 1.68 111.176 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 218' ' ' ILE . 23.9 t -64.82 -45.48 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.889 -0.596 . . . . 0.74 110.246 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.93 -31.42 59.11 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 109.098 -0.705 . . . . 1.24 109.098 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.73 -32.52 73.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.587 -0.733 . . . . 2.06 109.707 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.24 -28.03 22.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 2.98 109.574 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 222' ' ' VAL . 1.2 mt-30 -79.51 8.31 6.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.733 -0.667 . . . . 2.26 110.781 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -72.28 73.01 0.95 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.657 0.741 . . . . 3.87 110.465 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.4 t -90.36 27.82 1.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.525 -1.216 . . . . 4.45 111.363 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 230' ' ' PRO . . . -74.93 110.34 9.72 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.664 0.268 . . . . 4.8 110.471 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 229' ' ' ALA . 7.4 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.832 2.354 . . . . 7.05 112.375 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.861 0.362 . . . . 5.4 110.957 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -96.46 27.05 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 3.41 111.211 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.532 HG22 ' CZ ' ' A' ' 167' ' ' PHE . 60.0 mt -93.7 94.51 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.426 0.632 . . . . 1.21 110.617 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 mtm -139.76 130.28 25.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.816 -1.084 . . . . 2.59 110.854 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.46 141.81 55.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.823 -0.626 . . . . 2.39 111.044 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.37 170.26 53.64 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.713 -0.676 . . . . 1.81 113.181 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.69 -47.66 10.72 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.55 2.166 . . . . 1.93 111.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.38 36.29 4.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.91 -0.586 . . . . 2.65 111.06 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -88.41 137.99 31.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.104 -0.498 . . . . 2.61 110.109 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 166' ' ' ASP . 0.4 OUTLIER -71.28 160.21 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.15 0.5 . . . . 2.04 111.788 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.873 ' CE2' HG21 ' A' ' 222' ' ' VAL . 3.8 t80 -57.47 -52.0 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 1.55 111.493 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.4 -21.37 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.213 -0.449 . . . . 1.53 111.744 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 163' ' ' SER . 3.9 m-20 -72.56 -52.29 16.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 2.04 110.395 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.532 ' CZ ' HG22 ' A' ' 156' ' ' ILE . 50.3 t80 -63.22 -55.56 23.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.32 -0.4 . . . . 1.7 111.595 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.757 ' O ' HG12 ' A' ' 172' ' ' ILE . . . -50.39 -26.21 4.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.015 0.746 . . . . 0.67 113.015 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -37.16 55.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.152 -0.684 . . . . 1.73 109.152 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 mtt-85 -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.587 -1.264 . . . . 2.65 107.587 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.759 HD23 HG23 ' A' ' 189' ' ' ILE . 25.0 tp -67.7 -66.86 0.51 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.514 -0.766 . . . . 0.53 110.615 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 168' ' ' ALA . 44.0 mm -46.71 -52.86 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.717 -0.674 . . . . 1.02 112.032 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -61.35 -40.17 93.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.772 -0.649 . . . . 2.88 109.53 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.31 -38.72 91.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 0.82 110.67 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 171' ' ' LEU . 92.6 t -70.74 -42.35 77.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.99 111.655 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.44 -35.85 78.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.775 0.797 . . . . 2.71 110.127 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -69.91 -16.19 72.3 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.343 -1.299 . . . . 1.48 112.561 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.38 176.84 7.02 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.073 0.464 . . . . 1.63 111.291 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.84 18.93 4.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.622 . . . . 2.29 112.303 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.77 HD13 HG21 ' A' ' 188' ' ' VAL . 48.4 mt -70.02 133.82 87.82 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 112.081 0.4 . . . . 1.53 112.081 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 16.4 Cg_exo -66.76 156.87 63.91 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.847 2.365 . . . . 1.04 111.964 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.533 ' HA ' ' HG3' ' A' ' 185' ' ' ARG . 87.7 Cg_exo -52.82 -49.17 18.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.974 2.449 . . . . 1.32 112.62 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.7 m -66.76 -23.02 66.03 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.735 0.643 . . . . 1.46 112.735 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -100.6 -4.9 27.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.962 0.727 . . . . 0.9 112.962 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.533 ' HG3' ' HA ' ' A' ' 182' ' ' PRO . 6.9 mtm180 -62.88 -48.24 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 2.82 110.83 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.889 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -57.14 -63.6 3.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.56 111.293 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 81.6 Cg_exo -43.27 -29.22 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.58 112.859 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.77 HG21 HD13 ' A' ' 180' ' ' LEU . 98.4 t -71.1 -53.15 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.967 -0.753 . . . . 0.63 108.967 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.759 HG23 HD23 ' A' ' 171' ' ' LEU . 1.8 mp -61.3 -36.23 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.89 110.932 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 186' ' ' ALA . 42.9 mm -55.53 -62.24 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.67 110.188 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.222 0.453 . . . . 1.61 112.222 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -60.13 -46.37 89.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.27 -0.423 . . . . 0.81 110.251 -178.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 197' ' ' SER . 15.0 m-85 -57.89 -57.43 12.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.01 -0.541 . . . . 1.45 110.824 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.507 ' HG3' ' CG2' ' A' ' 205' ' ' ILE . 9.4 mtp180 -54.58 -13.6 1.03 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.777 0.658 . . . . 2.44 112.777 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 191' ' ' ASP . 16.7 pt20 -123.54 -8.83 7.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.326 0.862 . . . . 1.69 113.326 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.465 ' HG2' ' HG3' ' A' ' 195' ' ' GLN . 27.7 mmtt -123.13 -13.38 7.76 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.305 0.483 . . . . 2.68 112.305 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 193' ' ' PHE . 0.4 OUTLIER -79.15 158.71 27.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 1.57 111.208 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 166.65 4.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 2.57 111.142 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.16 -27.18 72.86 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.589 2.192 . . . . 1.5 111.774 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.29 -41.49 76.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 2.54 111.208 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.5 mm -87.21 -46.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.308 -0.406 . . . . 0.9 111.099 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -54.13 -34.36 60.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.998 -0.546 . . . . 1.56 111.754 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -38.79 88.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 2.22 110.646 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 208' ' ' ALA . 10.7 mt -70.04 -47.6 61.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.08 -0.964 . . . . 1.85 110.333 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.507 ' CG2' ' HG3' ' A' ' 194' ' ' ARG . 66.6 mt -68.03 -37.74 78.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.839 . . . . 0.94 111.032 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.46 -55.2 31.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.294 -0.866 . . . . 3.12 112.365 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.09 13.15 24.72 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.559 -0.456 . . . . 1.96 111.171 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 1.061 ' HB2' ' O ' ' A' ' 204' ' ' LEU . . . -60.9 128.08 88.48 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 1.4 111.575 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 208' ' ' ALA . 9.4 Cg_exo -71.27 -160.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.804 2.336 . . . . 2.29 111.587 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.99 159.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.11 0.481 . . . . 2.27 111.056 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.67 80.71 2.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.574 -0.739 . . . . 2.65 110.119 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 221' ' ' TYR . 1.7 mp -93.76 80.1 4.22 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.394 -0.965 . . . . 1.51 108.394 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 p -119.51 15.82 12.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.472 -0.785 . . . . 1.84 112.162 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.407 ' O ' HG13 ' A' ' 218' ' ' ILE . 1.5 p -147.33 167.37 13.69 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.06 110.8 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.1 -42.2 0.79 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.987 2.458 . . . . 0.76 109.942 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -53.97 -20.31 13.59 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.119 -1.401 . . . . 0.82 112.496 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.63 -39.23 9.2 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.907 0.384 . . . . 2.38 111.368 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.936 ' O ' HG23 ' A' ' 222' ' ' VAL . 9.9 mt -63.06 -50.77 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 1.05 110.671 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.572 HG13 ' HE2' ' A' ' 164' ' ' PHE . 3.6 mp -62.32 -40.26 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 CA-C-O 121.071 0.463 . . . . 0.81 110.187 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -37.85 88.88 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.354 -0.839 . . . . 3.05 108.759 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.528 ' CD2' HD21 ' A' ' 212' ' ' LEU . 33.2 t80 -72.86 -37.5 67.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.482 -0.781 . . . . 1.68 111.176 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 218' ' ' ILE . 23.9 t -64.82 -45.48 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.889 -0.596 . . . . 0.74 110.246 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.93 -31.42 59.11 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 109.098 -0.705 . . . . 1.24 109.098 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.73 -32.52 73.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.587 -0.733 . . . . 2.06 109.707 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.24 -28.03 22.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 2.98 109.574 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 222' ' ' VAL . 1.2 mt-30 -79.51 8.31 6.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.733 -0.667 . . . . 2.26 110.781 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -72.28 73.01 0.95 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.657 0.741 . . . . 3.87 110.465 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.4 t -90.36 27.82 1.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.525 -1.216 . . . . 4.45 111.363 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 230' ' ' PRO . . . -74.93 110.34 9.72 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.664 0.268 . . . . 4.8 110.471 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 229' ' ' ALA . 7.4 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.832 2.354 . . . . 7.05 112.375 -179.313 . . . . . . . . 1 1 . 1 stop_ save_